Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
MMWR Morb Mortal Wkly Rep ; 67(17): 491-495, 2018 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-29723171

RESUMEN

In 2005, the Regional Committee for the World Health Organization (WHO) Western Pacific Region (WPR)* established a goal for measles elimination† by 2012 (1). To achieve this goal, the 37 WPR countries and areas implemented the recommended strategies in the WPR Plan of Action for Measles Elimination (2) and the Field Guidelines for Measles Elimination (3). The strategies include 1) achieving and maintaining ≥95% coverage with 2 doses of measles-containing vaccine (MCV) through routine immunization services and supplementary immunization activities (SIAs), when required; 2) conducting high-quality case-based measles surveillance, including timely and accurate testing of specimens to confirm or discard suspected cases and detect measles virus for genotyping and molecular analysis; and 3) establishing and maintaining measles outbreak preparedness to ensure rapid response and appropriate case management. This report updates the previous report (4) and describes progress toward measles elimination in WPR during 2013-2017. During 2013-2016, estimated regional coverage with the first MCV dose (MCV1) decreased from 97% to 96%, and coverage with the routine second MCV dose (MCV2) increased from 91% to 93%. Eighteen (50%) countries achieved ≥95% MCV1 coverage in 2016. Seven (39%) of 18 nationwide SIAs during 2013-2017 reported achieving ≥95% administrative coverage. After a record low of 5.9 cases per million population in 2012, measles incidence increased during 2013-2016 to a high of 68.9 in 2014, because of outbreaks in the Philippines and Vietnam, as well as increased incidence in China, and then declined to 5.2 in 2017. To achieve measles elimination in WPR, additional measures are needed to strengthen immunization programs to achieve high population immunity, maintain high-quality surveillance for rapid case detection and confirmation, and ensure outbreak preparedness and prompt response to contain outbreaks.


Asunto(s)
Erradicación de la Enfermedad , Sarampión/epidemiología , Sarampión/prevención & control , Vigilancia de la Población , Adolescente , Asia Sudoriental/epidemiología , Australia/epidemiología , Niño , Preescolar , Brotes de Enfermedades/prevención & control , Asia Oriental/epidemiología , Genotipo , Humanos , Programas de Inmunización , Esquemas de Inmunización , Incidencia , Lactante , Sarampión/virología , Vacuna Antisarampión/administración & dosificación , Virus del Sarampión/genética , Islas del Pacífico/epidemiología , Cobertura de Vacunación/estadística & datos numéricos
3.
MMWR Morb Mortal Wkly Rep ; 64(13): 357-62, 2015 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-25856257

RESUMEN

In 2005, the Regional Committee for the World Health Organization (WHO) Western Pacific Region (WPR) established a goal to eliminate measles by 2012.The recommended elimination strategies in WPR include 1) ≥95% 2-dose coverage with measles-containing vaccine (MCV) through routine immunization services and supplementary immunization activities (SIAs); 2) high-quality case-based measles surveillance; 3) laboratory surveillance with timely and accurate testing of specimens to confirm or discard suspected cases and detect measles virus genotypes; and 4) measles outbreak preparedness, rapid response, and appropriate case management. In the WPR, the Philippines set a national goal in 1998 to eliminate measles by 2008. This report describes progress toward measles elimination in the Philippines during 1998-2014 and challenges remaining to achieve the goal. WHO-United Nations Children's Fund (UNICEF)-estimated coverage with the routine first dose of MCV (MCV1) increased from 80% in 1998 to 90% in 2013, and coverage with the routine second dose of MCV (MCV2) increased from 10% after nationwide introduction in 2010 to 53% in 2013. After nationwide SIAs in 1998 and 2004, historic lows in the numbers and incidence of reported measles cases occurred in 2006. Despite nationwide SIAs in 2007 and 2011, the number of reported cases and incidence generally increased during 2007-2012, and large measles outbreaks occurred during 2013-2014 that affected infants, young children, older children, and young adults and that were prolonged by delayed and geographically limited outbreak response immunization activities during 2013-2014. For the goal of measles elimination in WPR to be achieved, sustained investments are required in the Philippines to strengthen health systems, implement the recommended elimination strategies, and develop additional strategies to identify and reduce measles susceptibility in specific geographic areas and older age groups.


Asunto(s)
Erradicación de la Enfermedad , Vacuna Antisarampión/administración & dosificación , Sarampión/prevención & control , Vigilancia de la Población , Adolescente , Adulto , Niño , Preescolar , Genotipo , Humanos , Programas de Inmunización , Incidencia , Lactante , Recién Nacido , Sarampión/epidemiología , Virus del Sarampión/genética , Filipinas/epidemiología , Adulto Joven
4.
Vaccine ; 31 Suppl 9: J85-92, 2013 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-24331026

RESUMEN

WHO's Western Pacific Region has the highest rates of hepatitis B virus (HBV) infection in the world; most countries have >8% prevalence of HBV chronic infection in their adult population. In 2005, Member States of the Region adopted a resolution to reduce chronic hepatitis B infection prevalence to less than 2% among children by 2012 as an interim milestone toward a regional goal of less than 1% prevalence. Country commitments to hepatitis B control and successes represent a remarkable public health achievement by preventing over 1 million chronic infections and 300,000 HBV-related deaths per birth cohort. Reported here is a review of the process and strategies for translating this public health initiative into practice including such activities as setting up an Expert Resource Panel, developing implementation guidelines, focusing on facility births while supporting efforts to reach home births, providing guidance for conducting seroprevalence surveys, and establishing a verification process.


Asunto(s)
Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/organización & administración , Hepatitis B Crónica/epidemiología , Hepatitis B Crónica/prevención & control , China/epidemiología , Hepatitis B Crónica/mortalidad , Humanos , Análisis de Supervivencia , Organización Mundial de la Salud
5.
J Infect Dis ; 204 Suppl 1: S439-46, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21666197

RESUMEN

BACKGROUND: The 37 countries and areas of the World Health Organization (WHO) Western Pacific Region have targeted measles for elimination by 2012. METHODS: We reviewed routine and supplementary immunization coverage based on 2010 WHO/United Nation's Children's Fund (UNICEF) estimates and Joint Reporting Forms and epidemiologic and laboratory data submitted by the countries and areas. RESULTS: In 2009, 21 of 37 countries and areas had ≥90% coverage with a first dose of measles vaccine; 32 countries and areas provided 2 routine doses of measles vaccine with 94% weighted average coverage among those reporting. From 1996 to 2009, 235 million persons received measles vaccine during 94 immunization campaigns in 30 countries and areas. As of 2009, 2.8 suspected cases per 100,000 population were discarded as nonmeasles; however, only 43% of second level administrative units reported at least 1 discarded case per 100,000. Adequate specimen collection rate was 71%. Measles incidence was 34 per million population in 2009, a 58% decrease compared with 2008 and the lowest ever reported. As many as 25 countries and areas already may have eliminated measles. CONCLUSIONS: Achieving the 2012 measles elimination goal is feasible provided political and financial commitments are increased at every level to further improve routine and supplementary immunization activity (SIA) coverage and surveillance in every district.


Asunto(s)
Vacuna Antisarampión/administración & dosificación , Sarampión/epidemiología , Sarampión/prevención & control , Adolescente , Adulto , Asia Sudoriental/epidemiología , Australasia/epidemiología , Niño , Preescolar , Asia Oriental/epidemiología , Humanos , Programas de Inmunización , Esquemas de Inmunización , Incidencia , Lactante , Factores de Tiempo , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...